To the best of our knowledge, these results demonstrate for the first time that, along with the efficacy on adaptive immune cells and adipocytes, selective ROCK2 inhibition exerts an anti-inflammatory effect on several innate immune cells that have a predominant role in liver disease and fibrosis: liver resident Kupffer cells and monocytes that infiltrate the liver. This evidence concerns the gene ROCK2 and liver disorder.